γ-hydroxybutyrate (GHB)-induced respiratory depression: Combined receptor-transporter inhibition therapy for treatment in GHB overdose

Molecular Pharmacology

Volumn 82, Issue 2, 2012, Pages 226-235

  Morse, Bridget L ^a   Vijay, Nisha ^a   Morris, Marilyn E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; BICUCULLINE; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING RATE; CONTROLLED STUDY; DRUG OVERDOSE; KIDNEY CLEARANCE; LUNG MINUTE VOLUME; MALE; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; RESPIRATION DEPRESSION; TIDAL VOLUME;

ANIMALS; BICUCULLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHOLINES; OVERDOSE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RESPIRATORY INSUFFICIENCY; SODIUM OXYBATE; TREATMENT OUTCOME;

EID: 84863884501     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.078154     Document Type: Article

References (37)

1. Bernasconi R, Lauber J, Marescaux C, Vergnes M, Martin P, Rubio V, Leonhardt T, Reymann N, and Bittiger H (1992) Experimental absence seizures: potential role of γ-hydroxybutyric acid and GABAB receptors. J Neural Transm Suppl 35:155-177.
2. Bolser DC, Blythin DJ, Chapman RW, Egan RW, Hey JA, Rizzo C, Kuo SC, and Kreutner W (1995) The pharmacology of SCH 50911: a novel, orally-active GABA-β receptor antagonist. J Pharmacol Exp Ther 274:1393-1398.
3. Brenneisen R, Elsohly MA, Murphy TP, Passarelli J, Russmann S, Salamone SJ, and Watson DE (2004) Pharmacokinetics and excretion of γ- hydroxybutyrate (GHB) in healthy subjects. J Anal Toxicol 28:625-630.
4. Caldicott DG, Chow FY, Burns BJ, Felgate PD, and Byard RW (2004) Fatalities associated with the use of γ-hydroxybutyrate and its analogues in Australasia. Med J Aust 181:310-313.
5. B receptors in the sedative/hypnotic effect of γ-hydroxybutyric acid. Eur J Pharmacol 428:315-321.
6. Carai MA, Colombo G, and Gessa GL (2005) Resuscitative effect of a γ-aminobutyric acid B receptor antagonist on γ-hydroxybutyric acid mortality in mice. Ann Emerg Med 45:614-619.
7. Felmlee MA, Krzyzanski W, Morse BL, and Morris ME (2011) Use of a local sensitivity analysis to inform study design based on a mechanistic toxicokinetic model for γ-hydroxybutyric acid. AAPS J 13:240-254.
8. Felmlee MA, Roiko SA, Morse BL, and Morris ME (2010a) Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid. J Pharmacol Exp Ther 333:764-771.
9. Felmlee MA, Wang Q, Cui D, Roiko SA, and Morris ME (2010b) Mechanistic toxicokinetic model for γ-hydroxybutyric acid: inhibition of active renal reabsorption as a potential therapeutic strategy. AAPS J 12:407-416.
10. Fung HL, Haas E, Raybon J, Xu J, and Fung SM (2004) Liquid chromatographicmass spectrometric determination of endogenous gamma-hydroxybutyrate concentrations in rat brain regions and plasma. J Chromatogr B Analyt Technol Biomed Life Sci 807:287-291.
11. Fung HL, Tsou PS, Bulitta JB, Tran DC, Page NA, Soda D, and Mi Fung S (2008) Pharmacokinetics of 1,4-butanediol in rats: bioactivation to γ-hydroxybutyric acid, interaction with ethanol, and oral bioavailability. AAPS J 10:56-69.
12. Galicia M, Nogue S, and Miró O (2011) Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients. Emerg Med J 28:462-466.
13. Gobaille S, Hechler V, Andriamampandry C, Kemmel V, and Maitre M (1999) γ-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo. J Pharmacol Exp Ther 290:303-309.
14. Gorman JM, Raymond RG, Uy J, Ross D, Martinez J, Fyer AJ, Liebowitz MR, and Klein DF (1988) Hyperventilation occurs during lactate-induced panic. J Anxiety Disord 2:193-202.
15. Hechler V, Ratomponirina C, and Maitre M (1997) γ-Hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide. J Pharmacol Exp Ther 281:753-760.
16. 1-deficient mice. Eur J Neurosci 18:2722-2730.
17. Laborit H (1964) Sodium 4-hydroxybutyrate. Int J Neuropharmacol 3:433-451.
18. 14C-γ-hydroxybutyric acid. Res Commun Chem Pathol Pharmacol 13:425-437.
19. Lettieri J and Fung HL (1978) Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium γ-hydroxybutyrate and γ-butyrolactone. Res Commun Chem Pathol Pharmacol 22:107-118.
20. Lettieri JT and Fung HL (1979) Dose-dependent pharmacokinetics and hypnotic effects of sodium γ-hydroxybutyrate in the rat. J Pharmacol Exp Ther 208:7-11.
21. Li J, Stokes SA, and Woeckener A (1998) A tale of novel intoxication: seven cases of γ-hydroxybutyric acid overdose. Ann Emerg Med 31:723-728.
22. Liechti ME and Kupferschmidt H (2004) γ-Hydroxybutyrate (GHB) and γ-butyrolactone (GBL): analysis of overdose cases reported to the Swiss Toxicological Information Centre. Swiss Med Wkly 134:534-537.
23. MaitreM(1997) The γ-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337-361.
24. Mason PE and Kerns WP 2nd (2002) γ Hydroxybutyric acid (GHB) intoxication. Acad Emerg Med 9:730-739.
25. Metcalfe HK, Monson JP, Welch SG, and Cohen RD (1986) Inhibition of lactate removal by ketone bodies in rat liver. Evidence for a quantitatively important role of the plasma membrane lactate transporter in lactate metabolism. J Clin Invest 78:743-747.
26. Morris ME, Hu K, and Wang Q (2005) Renal clearance of γ-hydroxybutyric acid in rats: increasing renal elimination as a detoxification strategy. J Pharmacol Exp Ther 313:1194-1202.
27. Morris ME, Morse BL, Baciewicz GJ, Tessena MM, Acquisto NM, Hutchinson DJ, and DiCenzo R (2011) Monocarboxylate transporter inhibition with osmotic diuresis increases γ-hydroxybutyrate renal elimination in humans: a proof-of-concept study. J Clinic Toxicol 1.
28. Olsson M, Ho HP, Annerbrink K, Thylefors J, and Eriksson E (2002) Respiratory responses to intravenous infusion of sodium lactate in male and female Wistar rats. Neuropsychopharmacology 27:85-91.
29. Palatini P, Tedeschi L, Frison G, Padrini R, Zordan R, Orlando R, Gallimberti L, Gessa GL, and Ferrara SD (1993) Dose-dependent absorption and elimination of γ-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol 45:353-356.
30. Sporer KA, Chin RL, Dyer JE, and Lamb R (2003) γ-Hydroxybutyrate serum levels and clinical syndrome after severe overdose. Ann Emerg Med 42:3-8.
31. Substance Abuse and Mental Health Services Administration (2011) Drug Abuse Warning Network, 2008: National Estimates of Drug-Related Emergency Department Visits. HHS Publ. No. SMA 11-4618. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, Rockville, MD.
32. Tappy L, Cayeux MC, and Chioléro R (1996) Effects of sodium lactate on ventilation and acid-base balance in healthy humans. Clin Physiol 16:393-401.
33. Wang Q, Darling IM, and Morris ME (2006) Transport of γ-hydroxybutyrate in rat kidney membrane vesicles: role of monocarboxylate transporters. J Pharmacol Exp Ther 318:751-761.
34. Wang Q and Morris ME (2007) The role of monocarboxylate transporter 2 and 4 in the transport of γ-hydroxybutyric acid in mammalian cells. Drug Metab Dispos 35:1393-1399.
35. Wang Q, Wang X, and Morris ME (2008a) Effects of L-lactate and D-mannitol on γ-hydroxybutyrate toxicokinetics and toxicodynamics in rats. Drug Metab Dispos 36:2244-2251.
36. Wang X, Wang Q, and Morris ME (2008b) Pharmacokinetic interaction between the flavonoid luteolin and γ-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters. AAPS J 10:47-55.
37. Zvosec DL, Smith SW, Porrata T, Strobl AQ, and Dyer JE (2011) Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma. Am J Emerg Med 29:319-332.